Sharda Cropchem (SHARDACROP) investor relations material

Executive summary

• Achieved record annual PAT of ₹681 crore, highest ever EBITDA, and strongest revenue performance in FY 2026, driven by robust growth in agrochemical and non-agrochemical segments, despite global headwinds.

• Maintained an asset-light business model focused on product registrations and global marketing/distribution, with 3,011 registrations and 1,004 applications in pipeline as of March 2026.

• Expanded global presence to 80+ countries, leveraging a wide distribution network and growing sales force, especially in Europe and LATAM.

• Audited consolidated and standalone financial results for FY 2026 were approved with no audit qualifications or reservations.

• Board recommended a final dividend of INR 9 per share for FY 2026, in addition to an interim dividend of INR 6 per share.

Financial highlights

• FY 2026 revenue rose 22% year-on-year to INR 5,268 crore, with Q4 revenue up 13% to INR 2,065 crore.

• EBITDA increased 69% to INR 1,040 crore (margin 19.7%), and PAT surged 124% to INR 681 crore (PAT margin 12.9%).

• Q4 EBITDA rose 75% year-on-year to INR 513 crore (margin 24.8%); Q4 PAT up 57% to INR 319 crore.

• Gross margin expanded by 600 bps for the year to 35.9% and by 750 bps in Q4 to 37.3%.

• Earnings per share for FY 2026 stood at INR 75.47, up from INR 33.74 in FY 2025.

Outlook and guidance

• FY 2027 revenue expected to grow 10%-15%, with gross margins around 35% and EBITDA margin 18%-20%.

• Volume growth for FY 2027 projected at 15%; effective tax rate guided at 18%-20%.

• Continued focus on expanding product registrations, operational efficiencies, and deeper market penetration in existing and new geographies.

• Agrochemicals segment is seasonal, with performance influenced by cropping patterns and global weather conditions.